SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-22-005380
Filing Date
2022-02-14
Accepted
2022-02-14 17:02:41
Documents
1
Group Members
DAVID C. OTTO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTERVIKING GLOBAL OPPORTUNITIES LIQUID PORTFOLIO SUB-MASTER LPVIKING GLOBAL OPPORTUNITIES PARENT GP LLCVIKING GLOBAL OPP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10033306_sc13ga.htm SC 13G/A 292745
  Complete submission text file 0001140361-22-005380.txt   294709
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91705 | Film No.: 22634300
SIC: 2836 Biological Products, (No Diagnostic Substances)